Is it going to be that 5th time is the charm?
We started playing the game along with them…and I guess they presume we ain’t gonna stop now.
Since they ain’t stopping for sure!
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
“A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday,” Bloomberg reported.
“Two weeks after the start of the trial of 154 medical personnel at the Sheba Medical Center in Tel Aviv, researchers found the vaccine raised antibody levels,” the report noted.
“But that only offered a partial defense against omicron, according to Gili Regev-Yochay, the trial’s lead researcher,” the report continued. “Vaccines which were more effective against previous variants offer less protection with omicron, she said. Still, those infected in the trial had only slight symptoms or none at all.”
“A year after rolling out the world’s fastest coronavirus vaccination program, Israel again finds itself a global test case as it begins widely delivering fourth doses amid a surge in the omicron variant,” the report stated.
“Although the number of serious cases and deaths remain well below last year’s peak, infections have skyrocketed to record levels and could once again threaten to overwhelm hospitals if the new daily caseload reaches 50,000 as Israeli Prime Minister Naftali Bennett has warned,” the report continued. “Many of the newly infected were vaccinated at least twice.”
As previously reported, a Harvard study of 68 nations and 2,947 counties in the United States published in the European Journal of Epidemiology showed conclusively that the Covid ‘vaccines’ did not stop the spread of the Delta variant. The Omicron variant has demonstrated again that the mRNA shots are powerless to stop infections or transmission.
However, a South African study showed that even unvaccinated people infected with the Omicron variant were less likely to fall seriously ill, require hospitalization or die compared to prior COVID-19 variants, the New York Post reported.
“After adjusting for age, sex, comorbidities, and subdistrict there was a substantially reduced hazard of death in wave four compared to wave three,” the study concluded.